Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

Merz Therapeutics to present 11 abstracts at ISPRM World Congress 2026, highlighting its commitment to improving outcomes for people living with movement disorders Updated analysis indicates that ...

Managing spasticity involves a comprehensive approach that combines medical treatments such as oral medications and Botox injections with daily self-care practices, including stretching, exercise, and ...

Spasticity is when your muscles become tight, making them hard to move. Depending on the severity of your symptoms, treatment can involve medication, physical or occupational therapy, or surgery.

Animal or in vitro studies, studies performed in pediatric populations, and studies reporting treatment with BoNT products other than onabotulinumtoxinA were excluded. The full-text publications of ...

Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced it will present 11 scientific abstracts at the International Society of Physical and Rehabilitation Medicine ...